BAJAJ BROKING

Notification close image
No new Notification messages
card image
Oswal Pumps IPO is Open!
Apply for the Oswal Pumps IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

4136

524396

BIOFILCHEM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

BIOFIL CHEM & PHARMA LTD performance

Today’s low

Today’s high

₹ 49.20 ₹ 50.93
₹ 50.02

52 week low

52 week high

₹ 40.40 ₹ 91.87
₹ 50.02

Open Price

₹ 49.20

Prev. Close

₹ 50.14

Volume (Shares)

13565.00

Total traded value

₹ 6.78

Upper Circuit

₹ 60.16

Lower Circuit

₹ 40.11

info

BIOFIL CHEM & PHARMA LTD Share Price Update

As of the latest trading session, BIOFIL CHEM & PHARMA LTD share price is currently at ₹ 50.02, which is down by ₹ -0.11 from its previous closing. Today, the stock has fluctuated between ₹ 49.20 and ₹ 50.93. Over the past year, BIOFIL CHEM & PHARMA LTD has achieved a return of -19.67 %. In the last month alone, the return has been 15.02 %. Read More...

BIOFIL CHEM & PHARMA LTD fundamentals


  • Market cap (Cr)

    81.40

  • P/E Ratio (TTM)

    146.29

  • Beta

    1.40

  • Book Value / share

    11.54

  • Return on equity

    1.42%

  • EPS (TTM)

    0.34

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.20

info icon alternate text
  • Market cap (Cr)

    81.10

  • P/E Ratio (TTM)

    146.29

  • Beta

    1.37

  • Book Value / share

    11.54

  • Return on equity

    1.42%

  • EPS (TTM)

    0.34

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.20

info icon alternate text

BIOFIL CHEM & PHARMA LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 8.35
Operating Expense 8.34
Net Profit 0.20
Net Profit Margin (%) 2.39
Earnings Per Share (EPS) 0.12
EBITDA 0.34
Effective Tax Rate (%) 20.00
Particulars DEC 2024 (Values in Cr)
Revenue 14.20
Operating Expense 14.00
Net Profit 0.16
Net Profit Margin (%) 1.12
Earnings Per Share (EPS) 0.10
EBITDA 0.33
Effective Tax Rate (%) 27.27
Particulars SEP 2024 (Values in Cr)
Revenue 2.41
Operating Expense 2.40
Net Profit 0.02
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.01
EBITDA 0.14
Effective Tax Rate (%) 33.33
Particulars JUN 2024 (Values in Cr)
Revenue 8.44
Operating Expense 8.24
Net Profit 0.17
Net Profit Margin (%) 2.01
Earnings Per Share (EPS) 0.10
EBITDA 0.34
Effective Tax Rate (%) 26.08
Particulars MAR 2024 (Values in Cr)
Revenue 15.20
Operating Expense 15.33
Net Profit 0.25
Net Profit Margin (%) 1.64
Earnings Per Share (EPS) 0.15
EBITDA 0.37
Effective Tax Rate (%) 11.11
Particulars MAR 2025 (Values in Cr)
Revenue 33.40
Operating Expense 32.97
Net Profit 0.56
Net Profit Margin (%) 1.67
Earnings Per Share (EPS) 0.34
EBITDA 1.16
Effective Tax Rate (%) 24.32
Particulars MAR 2024 (Values in Cr)
Revenue 40.04
Operating Expense 39.66
Net Profit 0.71
Net Profit Margin (%) 1.77
Earnings Per Share (EPS) 0.44
EBITDA 1.31
Effective Tax Rate (%) 18.39
Particulars MAR 2023 (Values in Cr)
Revenue 30.04
Operating Expense 29.34
Net Profit 0.56
Net Profit Margin (%) 1.86
Earnings Per Share (EPS) 0.29
EBITDA 1.26
Effective Tax Rate (%) 29.11
Particulars MAR 2022 (Values in Cr)
Revenue 22.38
Operating Expense 21.52
Net Profit 0.70
Net Profit Margin (%) 3.12
Earnings Per Share (EPS) 0.44
EBITDA 1.48
Effective Tax Rate (%) 31.68
Particulars MAR 2021 (Values in Cr)
Revenue 35.75
Operating Expense 34.63
Net Profit 1.24
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.76
EBITDA 2.40
Effective Tax Rate (%) 35.41
Particulars MAR 2024 (Values in Cr)
Book Value / Share 11.19
ROE % 1.42
ROCE % 1.81
Total Debt to Total Equity 0.03
EBITDA Margin 3.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share 10.63
ROE % 1.12
ROCE % 1.65
Total Debt to Total Equity 0.03
EBITDA Margin 4.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 10.35
ROE % 1.40
ROCE % 2.11
Total Debt to Total Equity 0.03
EBITDA Margin 6.61
Particulars MAR 2021 (Values in Cr)
Book Value / Share 9.91
ROE % 2.49
ROCE % 3.92
Total Debt to Total Equity 0.05
EBITDA Margin 6.71
Particulars MAR 2020 (Values in Cr)
Book Value / Share 9.15
ROE % 2.43
ROCE % 3.10
Total Debt to Total Equity 0.10
EBITDA Margin 6.70
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 2.28
Total Assets 47.08
Total Liabilities 47.08
Total Equity 18.20
Share Outstanding 16273800
Price to Book Ratio 5.39
Return on Assets (%) 1.50
Return on Capital (%) 3.8
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 31.40
Total Liabilities 31.40
Total Equity 17.30
Share Outstanding 16273800
Price to Book Ratio 3.90
Return on Assets (%) 1.78
Return on Capital (%) 3.14
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.14
Total Assets 18.73
Total Liabilities 18.73
Total Equity 16.83
Share Outstanding 16273800
Price to Book Ratio 5.58
Return on Assets (%) 3.72
Return on Capital (%) 4.04
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.44
Total Assets 33.23
Total Liabilities 33.23
Total Equity 16.12
Share Outstanding 16273800
Price to Book Ratio 6.62
Return on Assets (%) 3.73
Return on Capital (%) 7.5
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.25
Total Assets 42.36
Total Liabilities 42.36
Total Equity 14.88
Share Outstanding 16273800
Price to Book Ratio 0.81
Return on Assets (%) 2.84
Return on Capital (%) 7.51
Particulars MAR 2024 (Values in Cr)
Net Income 0.86
Cash from Operations 2.54
Cash from Investing -0.02
Cash from Financing -0.12
Net change in Cash 2.24
Free Cash Flow 2.57
Particulars MAR 2023 (Values in Cr)
Net Income 0.79
Cash from Operations 0.12
Cash from Investing -0.01
Cash from Financing 0.01
Net change in Cash -0.10
Free Cash Flow 0.13
Particulars MAR 2022 (Values in Cr)
Net Income 1.01
Cash from Operations 0.09
Cash from Investing -0.06
Cash from Financing 0.00
Net change in Cash -0.29
Free Cash Flow 0.16
Particulars MAR 2021 (Values in Cr)
Net Income 1.91
Cash from Operations 1.78
Cash from Investing -0.09
Cash from Financing -0.83
Net change in Cash 0.18
Free Cash Flow 2.35
Particulars MAR 2020 (Values in Cr)
Net Income 1.46
Cash from Operations 1.15
Cash from Investing -0.20
Cash from Financing -0.56
Net change in Cash 0.11
Free Cash Flow 1.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.36 27.76 1.99 278.64 34.11 / 77.70
BLISS GVS PHARMA LTD 149.35 18.67 1.49 1573.70 101.00 / 184.95
CIPLA LTD 1505.40 23.06 3.89 121589.70 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 338.10 12.94 2.74 995.06 163.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 3299.05 63.95 28.64 55887.90 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.36 36.36 5.74 278.64 34.11 / 77.70
AMRUTAJAN HEALTH LTD 697.60 39.68 6.17 2016.81 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 10524.65 150.31 34.15 26311.63 6160.25 / 10653.05
BLISS GVS PHARMA LTD 149.35 22.80 1.48 1573.70 101.00 / 184.95

BIOFIL CHEM & PHARMA LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
50.02 -0.23 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 51.40
  • 26 Days 49.10
  • 10 Days 51.10
  • 50 Days 48.10
  • 12 Days 50.80
  • 100 Days 49.70
  • 20 Days 49.70
  • 200 Days 53.40
50.45 PIVOT

First Support

49.19

First Resistance

51.39

Second Support

48.25

Second Resistance

52.65

Third Support

46.99

Third Resistance

53.59

RSI

53.90

ADX

45.50

MACD

1.73

Williams % R

-63.00

Commodity Channel Index (CCI)

27.80

Date

2025-06-13

Week

22518.00

Same Day

15875.00

Month

27941.00

1 Year

1.40

3 Year

1.11

Over 1 Month

15.02%

down

Over 1 Year

-19.67%

down

Over 3 Months

16.14%

down

Over 3 Years

-2.59%

down

Over 6 Months

-21.38%

down

Over 5 Years

31.50%

down

BIOFIL CHEM & PHARMA LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
53.1%
Promoter Holdings
46.81%
FII
0.0%
DII
0.08%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Scope Finance Company Private Limited 2262500.0 (13.9%) Shareholding of Promoter and Promoter Group
Starline Equifin Private Limited 1221368.0 (7.51%) Public Shareholding
Mid (india) Pharmaceuticals Pvt Ltd 1175250.0 (7.22%) Shareholding of Promoter and Promoter Group
Cyano Finance And Sales Pvt. Ltd. 876450.0 (5.39%) Shareholding of Promoter and Promoter Group
Meena Shah 627655.0 (3.86%) Shareholding of Promoter and Promoter Group
Ramesh Shah 493940.0 (3.04%) Shareholding of Promoter and Promoter Group
Ketan Shah 460405.0 (2.83%) Shareholding of Promoter and Promoter Group
Sandeep Shah 390155.0 (2.4%) Shareholding of Promoter and Promoter Group
Romil Shah 382550.0 (2.35%) Shareholding of Promoter and Promoter Group
Ksl And Industries Limited 308065.0 (1.89%) Public Shareholding
Niyati Shah 300000.0 (1.84%) Shareholding of Promoter and Promoter Group
Kishor Himmatsinh Jhala 198086.0 (1.22%) Public Shareholding
Gom Industries Ltd 180800.0 (1.11%) Public Shareholding
Smitesh Sanalal Shah 158005.0 (0.97%) Shareholding of Promoter and Promoter Group
Trupti Shah 101750.0 (0.63%) Shareholding of Promoter and Promoter Group
Ritu Shah 87100.0 (0.54%) Shareholding of Promoter and Promoter Group
Meet Shah 87200.0 (0.54%) Shareholding of Promoter and Promoter Group
Manali Simon 87200.0 (0.54%) Shareholding of Promoter and Promoter Group
Rohan Shah 65500.0 (0.4%) Shareholding of Promoter and Promoter Group
Kiran Shah 63100.0 (0.39%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

BIOFIL CHEM & PHARMA LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

BIOFIL CHEM & PHARMA LTD Share Price

Biofil Chemicals & Pharmaceuticals Limited (BCPL) was incorporated as a Private Limited Company on 4 Jan.'85 for manufacturing and trading of Pharmaceuticals products. Later on, the Company was converted into a Public Limited Company on 7 May '92. The Company deals in providing job work facility in respect of manufacturing of pharmaceuticals drug. It runs the business via two unit viz Pharmaceutical Division & Chemicals Division.

In Feb.'96, the company had come out with a rights-cum-public issue at a premium of Rs 7.50 and at a premium of Rs 12.50 respectively, both aggregating Rs 23.21 cr, to part-finance its expansion and diversification into bulk drugs and pharmaceutical formulations. The company currently manufactures pharmaceutical formulations like injections, capsules, eye-drops and dry syrups at its plant located in Indore.

BCPL's new unit was set up at Pithampur in Madhya Pradesh at a project costing Rs 39.75 cr. The Company entered into business partnership with HLL Lifecare Limited (Formerly Hindustan Latex Ltd) an undertaking of Government of India. As per the agreed terms it provided manufacturing facility to HLL Lifecare Limited for manufacturing of Iron and Folic Acid Tablets (IFA) and other Pharmaceuticals products as required by HLL.

Presently, the Company is flourishing business activates at Pithampur, in Madhya Pradesh. Now Company is not only dealing in the pharmaceutical product but has diversified its business activity in producing plastic products required for packing of pharmaceutical product and other plastic products.

Parent organization Systematix
NSE symbol BIOFILCHEM
Founded 1985
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

Biofil Chemicals & Pharmaceuticals Ltd share price is for NSE ₹ 50.02 & for BSE ₹ 49.86 as on Jun 16 2025 03:30 PM.

What is the Market Cap of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

The market cap of Biofil Chemicals & Pharmaceuticals Ltd for NSE ₹ 81.40 & for BSE ₹ 0.00 as on Jun 16 2025 03:30 PM.

What is the 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Biofil Chemicals & Pharmaceuticals Ltd for NSE is ₹ 91.87 and ₹ 40.40 and for BSE is ₹ 92.00 and ₹ 40.50.

What is 1 year return for Biofil Chemicals & Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -19.67%.

What is the P/E Ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 16 2025 03:30 PM the price-to-earnings (PE) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 146.29.

What is the PB ratio of Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

As on Jun 16 2025 03:30 PM, the price-to-book (PB) ratio for Biofil Chemicals & Pharmaceuticals Ltd share is 11.54.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share?

Answer Field

You can trade in Biofil Chemicals & Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Biofil Chemicals & Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Biofil Chemicals & Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Biofil Chemicals & Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|